Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
ALK重排肺癌对第三代ALK抑制剂劳拉替尼的多种耐药机制
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-19-1104
Gonzalo Recondo ,Laura Mezquita ,Francesco Facchinetti ,David Planchard ,Anas Gazzah ,Ludovic Bigot ,Ahsan Z Rizvi ,Rosa L Frias ,Jean Paul Thiery ,Jean-Yves Scoazec ,Tony Sourisseau ,Karen Howarth ,Olivier Deas ,Dariia Samofalova ,Justine Galissant ,Pauline Tesson ,Floriane Braye ,Charles Naltet ,Pernelle Lavaud ,Linda Mahjoubi ,Aurélie Abou Lovergne ,Gilles Vassal ,Rastilav Bahleda ,Antoine Hollebecque ,Claudio Nicotra ,Maud Ngo-Camus ,Stefan Michiels ,Ludovic Lacroix ,Catherine Richon ,Nathalie Auger ,Thierry De Baere ,Lambros Tselikas ,Eric Solary ,Eric Angevin ,Alexander M Eggermont ,Fabrice Andre ,Christophe Massard ,Ken A Olaussen ,Jean-Charles Soria ,Benjamin Besse ,Luc Friboulet